Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
81
PCT Quote, Financials, Valuation and Earnings
Last price:
$16.49
Seasonality move
:
3.24%
Day range:
$15.81 - $16.70
52-week range:
$4.50 - $16.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
12.44x
Volume:
4.5M
Avg. volume:
4.4M
1-year change:
168.73%
Market cap:
$3B
Revenue:
--
EPS (TTM):
-$1.17
Earnings Data
Next earnings date for PCT
Aug 08
2025
Most recent earnings per share
$0.05
Beat by $0.28
(May 7/2025)
Consensus Estimate
-$0.23
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PCT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $11.4M | -- | -- | -$0.20 | -- |
| 08/08/2025 | Q2 | $2.8M | -- | -- | -$0.20 | -- |
| 05/07/2025 | Q1 | $4.3M | $1.6M | $0.05 | -$0.23 | $0.28 |
| 02/27/2025 | Q4 | $3.8M | -- | -$0.39 | -$0.20 | -$0.19 |
| 11/07/2024 | Q3 | $401.2K | -- | -$0.54 | -$0.18 | -$0.36 |
| 08/08/2024 | Q2 | $1.2M | -- | -$0.29 | -$0.17 | -$0.12 |
| 05/07/2024 | Q1 | $900K | -- | -$0.52 | -- | -- |
| 03/06/2024 | Q4 | $178K | -- | -$0.18 | -$0.22 | $0.04 |
| 11/08/2023 | Q3 | -- | -- | $0.03 | -$0.17 | $0.20 |
| 08/09/2023 | Q2 | -- | -- | -$0.35 | -$0.12 | -$0.23 |
| 05/09/2023 | Q1 | -- | -- | -$0.16 | -$0.14 | -$0.02 |
| 03/16/2023 | Q4 | -- | -- | -$0.06 | -$0.14 | $0.08 |
| 11/10/2022 | Q3 | -- | -- | -$0.21 | -$0.12 | -$0.09 |
| 08/12/2022 | Q2 | -- | -- | -$0.09 | -$0.16 | $0.07 |
| 05/12/2022 | Q1 | -- | -- | -$0.19 | -- | -- |
| 03/03/2022 | Q4 | -- | -- | -$0.18 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.18 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.09 | -- | -- |
| 05/17/2021 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$1.21 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.28 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.19 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.03 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | $0.43 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | $0.42 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | $0.31 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | $0.25 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.30 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.51 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.36 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $0.48 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | $0.36 | -- | -- |
PureCycle Technologies Earnings Questions
-
How Much did PureCycle Technologies Generate in Revenue Last Quarter?
PureCycle Technologies reported $1.6M worth of top line sales in its most recent quarter.
-
Did PureCycle Technologies Beat Earnings Last Quarter?
PureCycle Technologies announced earnings per share of $0.05 which represents a beat of analyst forecast a -$0.23 per share.
-
Is PureCycle Technologies Profitable?
PureCycle Technologies reported -$21.7M that represents -$0.12 per share over the last quarter.
-
What is the Analyst Consensus for PureCycle Technologies EPS Next Year?
PureCycle Technologies's earnings are forecast to decrease from -$1.75 per share to -$1.47 per share next year representing a decrease of -65.71%.
-
When is PureCycle Technologies's Earnings Date?
PureCycle Technologies's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
